Liquid Biopsy

SlideShare_LabBench_LiquidBiopsy_700x233

Liquid biopsy resources on SlideShare

QIAGEN offers a complete, efficient and streamlined workflow to empower your liquid biopsy research. We have added our newest webinar presentations and videos covering circulating cell-free DNA, circulating tumor cells and exosomes to SlideShare. Whether you want to learn how to collect and stabilize blood samples, discover a complete and efficient workflow for ccfDNA analysis,… Read article →


5316_NGS_QIAseq_cfDNA_700x233

A 4-part webinar series on cfDNA in liquid biopsy

Integrated collection, stabilization and purification for the cfDNA workflow Facing challenges in your circulating cell-free DNA (cfDNA) analysis? We have everything you need to gain deep insight into cfDNA: a complete and streamlined workflow covering blood sample collection and stabilization, cfDNA isolation, sequencing analysis and data interpretation. Attend the 4-part webinar series to learn about new technologies. See… Read article →


10TopCTCsFAQs_700x233

Top 10 FAQs on circulating tumor cells

During the past 20 years, the interest in circulating tumor cells (CTCs) has increased dramatically due to their potential as circulating biomarkers in monitoring cancer progression and treatment. However, selecting and detecting CTCs from whole blood of cancer patients in the background of normal cells is very challenging. Since last summer, Dr. Siegfried Hauch, Director… Read article →


cfDNA_Discoveries_700x233

How to optimize the preanalytical portion of your circulating cell-free DNA (cfDNA) studies

Advances in liquid biopsy are allowing new strides in studies involving circulating cell-free DNA (cfDNA). With initial use in the prenatal testing field, cfDNA began to tell its story in fetal DNA genetic testing and has offered an alternative to the invasive and risk-prone amniocentesis. Now, it is breaking barriers in the field of cancer… Read article →


BreastCancer_Metastasis_700x233

Towards personalized cancer care: liquid biopsy for monitoring primary breast cancer

Breast cancer is the most common cancer in women, accounting for 23% of all cancer diagnoses (1). At the time of diagnosis, a majority of patients (>90%) will have localized disease, which is typically treated with surgery, radiation and therapeutic agents. Localized disease is associated with improved five-year survival rates, relative to more advanced cancers… Read article →